i
Superseded
This Document Has Been Replaced By:
i
Retired
This Document Has Been Retired
i
Up-to-date Information
This is the latest update:
HIV prevention with drug using populations. Current status and future prospects.
-
Published Date:
Jun 1998
-
Source:Public Health Rep. 113(Suppl 1):1-3
-
Language:English
-
Details:
-
Alternative Title:Public Health Rep
-
Personal Author:
-
Subject:
-
Pubmed ID:9750106
-
Pubmed Central ID:PMCnull
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:urn:sha256:55fc1bb759db01138b55df16b68a2aea26de36bfeca658d6c21303f37c5fe230
- File Type:
-
Supporting Files:No Additional Files
Related Documents:
-
-
Published Date:6-1998Source:Public Health Rep. 113(Suppl 1)Description:The National Institute on Drug Abuse (NIDA), in collaboration with the Office of AIDS Research of the National Institutes of Health, invited national and international researchers to the "Research Synthesis Symposium on the Prevention of HIV in Drug ...
Personal Author:Cottler, L B; Compton, W M; Ben Abdallah, A; Cunningham-Williams, R; Abram, F; Fichtenbaum, C; Dotson, W;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):31-41Description:The purpose of this chapter is to describe the results of a randomized study (funded by the National Institute on Drug Abuse [NIDA]) comparing a peer-delivered enhanced intervention to the NIDA standard intervention for reducing human immunodeficienc...
Personal Author:Latkin, C APublished Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):151-159Description:Guided by a social influence and empowerment framework, peer leaders in the injecting drug user (IDU) community were trained to promote human immunodeficiency virus (HIV) prevention among their contacts within and beyond their sex and drug networks.|...
Personal Author:Brooner, R; Kidorf, M; King, V; Beilenson, P; Svikis, D; Vlahov, D;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):129-139Description:Although lowering incidence rates of human immunodeficiency virus (HIV) transmission is the primary goal of needle exchange programs (NEPs), other desirable outcomes are possible. Referring exchange participants to more comprehensive drug abuse treat...
Personal Author:Valente, T W; Foreman, R K; Junge, B; Vlahov, D;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):90-96Description:Our first objective was to develop an index of satellite exchange and then determine whether satellite exchangers (SEs) differed demographically or behaviorally from other injecting drug users (IDUs). Our second objective was to determine the degree ...
Personal Author:Singer, M; Baer, H A; Scott, G; Horowitz, S; Weinstein, B;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):81-89Description:To break the link between drug use and the human immunodeficiency virus (HIV), in 1992 the state of Connecticut rescinded a 14-year ban on pharmacy sales of syringes without a physician's prescription. In 1993, the Center for Disease Control and Prev...
Personal Author:Ball, A L; Rana, S; Dehne, K L;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):170-181Description:Human immunodeficiency virus (HIV) infection associated with injecting drug use has been reported in at least 98 countries and territories worldwide. There is evidence that new epidemics are emerging in different regions, including Eastern Europe, La...
Personal Author:Coyle, S L; Needle, R H; Normand, J;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):19-30Description:Over the past decade, a body of observational research has accrued about the effects of outreach-based human immunodeficiency virus (HIV) interventions for drug users. The authors reviewed the findings related to postintervention behavior changes and...
Personal Author:Levy, J A; Fox, S E;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):160-169Description:This analysis describes the Outreach-Assisted Model of Partner Notification, an innovative strategy for encouraging seropositive injecting drug users (IDUs) to inform their partners of shared human immunodeficiency virus (HIV) exposure. The analysis ...
Personal Author:Booth, R E; Kwiatkowski, C; Iguchi, M Y; Pinto, F; John, D;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):116-128Description:High risk injection practices are common among injecting drug users (IDUs), even following intervention efforts. Moreover, relapse to risk behaviors has been reported among those who initiate risk reduction. Substance abuse treatment offers the poten...
Personal Author:Kumar, M S; Mudaliar, S; Daniels, D;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):58-66Description:Community-based outreach to drug injectors is an important component of human immunodeficiency virus (HIV) prevention strategy. The purpose of this chapter is to evaluate the effectiveness of community-based outreach HIV intervention that has been im...
Personal Author:Vlahov, D; Junge, B;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):75-80Description:Injecting drug users (IDUs) are at high risk for infection by human immunodeficiency virus (HIV) and other blood-borne pathogens. In the United States, IDUs account for nearly one-third of the cases of acquired immunodeficiency syndrome (AIDS), eithe...
Personal Author:Shriver, M; de Burger, R; Brown, C; Simpson, H L; Meyerson, B;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):189-193Description:Five policy advocates and practitioners provide recommendations to researchers to make research data more usable, accessible, and applicable for the field of human immunodeficiency virus (HIV) prevention among injecting and other drug users. Translat...
Personal Author:Metzger, D S; Navaline, H; Woody, G E;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):97-106Description:As the acquired immunodeficiency syndrome (AIDS) epidemic among drug users enters its third decade in the United States, it is important to consider the role playing by substance abuse treatment in the prevention of human immunodeficiency virus (HIV)...
Personal Author:Heimer, RPublished Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):67-74Description:This chapter attempts to describe the factors influencing the transmission of syringe-born viruses, to review the effects of syringe exchange programs (SEPs) in terms of these factors, and to explore the gamut of health-promoting activities of SEPs.|...
Personal Author:Neaigus, APublished Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):140-150Description:To review human immunodeficiency virus (HIV) risk reduction interventions among injecting drug users (IDUs) that have adopted a network approach.|The design and outcomes of selected network-based interventions among IDUs are reviewed using the networ...
Personal Author:Hartel, D M; Schoenbaum, E E;Published Date:Jun 1998Source:Public Health Rep. 113(Suppl 1):107-115Description:We undertook a study of the role of methadone maintenance in protecting injecting drug users (IDUs) from human immunodeficiency virus (HIV) infection from the earliest days of the HIV epidemic in New York City to the present. The historical context o...
-